AstraZeneca faces US class action lawsuit amidst China regulatory probes
The lawsuit claims that UK's largest listed company misled shareholders in connection with investigations by the Chinese government.
Article label: Quick Read
AstraZeneca PLC, the British-Swedish pharmaceutical giant, is facing a securities class action lawsuit in the US. The action alleges that the company misled investors about its business practices in China.
The lawsuit, filed in the US District Court for the Central District of California, claims that AstraZeneca made false and
